CRP and chronic kidney disease: Omega-3 polyunsaturated fatty acids (PUFAs), particularly EPA and DHA, have shown anti-inflammatory and antioxidant effects by reducing IL-6, TNF-α, and CRP levels and by inhibiting NLRP3 inflammasome activation, especially in CKD and dialysis patients [86,90].